Business Context and Reporting Period
This Form 8-K, filed on March 15, 1999, reports on events occurring on March 12, 1999, regarding E. I. du Pont de Nemours and Company (DuPont). The filing details a strategic meeting with investors where Chairman and CEO Charles O. Holliday, Jr. outlined a "Sustainable Growth Strategy." The company is transitioning its business model to be less capital-intensive and less cyclical, utilizing Six Sigma for productivity and adjusting its portfolio. DuPont also announced a new financial reporting structure effective with its 1998 annual report, organizing operations into eight reportable segments.
Key Financial Metrics
Based on the three-year summary data provided in the filing:
- Revenue: Total consolidated sales for 1998 were $24,767 million, compared to $24,089 million in 1997 and $23,644 million in 1996.
- Profitability: Reported Income from Continuing Operations for 1998 was $1,648 million (Diluted EPS $1.43). This contrasts with Underlying After-Tax Operating Income (ATOI) of $3,395 million for 1998, which excludes significant one-time charges.
- Capital Expenditures: The 1999 capital expenditure budget is approximately $2 billion, a reduction from $2.3 billion in 1998 (excluding discontinued Conoco operations).
- Assets: Total assets per consolidated financial statements were $38,536 million in 1998.
- Segment Performance: The Polyester Enterprise reported negative Underlying ATOI of $7 million in 1998, while Specialty Fibers and Specialty Polymers were the strongest performers with Underlying ATOI of $662 million and $608 million, respectively.
Material Changes and Strategic Shifts
Several material changes and strategic decisions were highlighted:
- Portfolio Adjustments: DuPont is in discussions with Pioneer Hi-Bred International Inc. regarding a possible business combination, though no assurances of a transaction exist. Negotiations with Tongkook, a Korean elastane fiber producer, have been terminated.
- Operational Restructuring: The company is implementing Six Sigma quality programs to drive cost reduction and revenue enhancement. The Polyester Enterprise is undergoing significant cost and capital reduction due to a cyclical trough.
- Life Sciences Focus: DuPont plans to aggressively grow its Life Sciences businesses (Crop Protection, Nutrition & Health, Pharmaceuticals) and has authorized the creation of a "tracking" stock for these units.
- Pharmaceuticals: The company expects to begin receiving its full 50% share of earnings from the antihypertension drug "Cozaar" by mid-2000 under an equalization agreement with Merck.
Guidance, Risks, and Unusual Items
Unusual Items and Charges: The 1998 reported earnings were significantly impacted by non-recurring charges, including a $799 million charge for purchased in-process research and development (IPR&D) related to the Merck pharmaceutical joint venture and a $54 million impairment write-down in Pharmaceuticals. The Nylon Enterprise also incurred a $162 million charge for productivity initiatives.
Outlook: Management expects positive impacts from Six Sigma initiatives as early as 1999. The company aims to transform into a faster-growing, more profitable, and less cyclical entity.
Risks: Forward-looking statements are subject to risks including changes in laws and regulations, competitive pressures, integration of structural changes, and Year 2000 compliance issues. There is no assurance that the Pioneer Hi-Bred transaction will be concluded.
Investor Verification Checklist
- Verify the status and potential terms of the business combination discussions with Pioneer Hi-Bred International Inc.
- Monitor the progress of the "tracking" stock for Life Sciences businesses and the timeline for full Cozaar earnings recognition.
- Assess the effectiveness of Six Sigma implementation in reducing costs and improving margins in 1999.
- Review the specific cost reduction and alliance strategies for the Polyester Enterprise to determine if the cyclical trough is being addressed.
- Confirm the final capital expenditure budget for 1999 against the stated $2 billion target.